Celebrating twenty years
By Chemistry World2008-04-28T10:55:00
Already troubled by disappointing clinical trial results and an ongoing investigation, US drug giants Merck and Schering Plough’s combined cholesterol treatment Vytorin has now received a damning review from leading cardiologists.